REGN7508 Versus Acetylsalicylic Acid (ASA) for Venous Thromboprophylaxis After Total Knee Arthroplasty in Adult Participants
Eligible age
18+ yrs
Accepts
All genders
Locations
16 states
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
This study is researching an experimental drug called REGN7508 (called "study drug") and how it compares against another treatment called Acetylsalicylic Acid (ASA). The study is focused on adults undergoing elective, unilateral (one side) total knee replacement surgery. The aim of the study is to see how effective the study drug is at preventing Venous Thromboembolism (VTE) and other related diseases after total knee replacement surgery compared to acetylsalicylic acid. The study is looking at several other research questions, including: * What side effects may happen from taking the study drug * How much study drug is in the blood at different times * Whether the body makes antibodies against the study drug (which could make the study drug less effective or could lead to side effects)
Sponsor: Regeneron Pharmaceuticals
Where it's recruiting
La Mesa · Rancho Mirage
Lone Tree
Deerfield Beach · Miami · Tamarac
Skokie
Indianapolis
Wichita
Annapolis · Baltimore
Boston
Teaneck
Rochester
Raleigh · Wilmington
Cincinnati · Columbus
Source: ClinicalTrials.gov · NCT07213778 · last updated 2026-07-22